Last updated: 13.02.2014

Address: Zernikedreef 12, 2333 CL Leiden,Netherlands

Tel: +31 (0)71 524 40 44

Web: http://www.octoplus.nl/

Company description

OctoPlus is a product-oriented drug delivery company focused on the development of improved pharmaceutical products with less side effects, increased patient compliance and better efficacy. Since our inception in 1995, we have established a successful track record and maintain partnerships with large and small biotech and pharma companies throughout the world.

Our business activities include formulation development services, drug delivery technologies and controlled release product development.

Products and services

OctoPlus uses its proprietary drug delivery technologies to develop controlled release products for clients.

OctoPlus has developed a number of proprietary drug delivery technologies that facilitate the controlled release of biologically active compounds. Our three main technology platforms enable us to develop tailor-made controlled release formulations for all classes of injectable drug compounds:

OctoDEX®: a dextran-based microsphere delivery technology for proteins and particulate systems.

PolyActive®: a biodegradable polymeric drug delivery system for the controlled release of proteins and lipophilic small molecules.

SynBiosys™: a biodegradable polymeric drug delivery system for the controlled release of peptides and small molecules (in collaboration with Innocore BV).



We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here